ABISA Expands with Clients in Switzerland

Monday, November 28, 2016 General News J E 4

TAMPA, Fla., Nov. 28, 2016 /PRNewswire/ -- ABISA, LLC, a leading independent healthcare consultancy, announced that the company has now engaged clients in Switzerland and is working with them to help advance a healthcare business initiative in Eastern Europe.

Photo -

In addition to its longstanding U.S. client base, ABISA also has worked with clients in the United Kingdom, the United Arab Emirates, Morocco, Puerto Rico, Australia, and Turkey. "We are excited with the company's continued international expansion," says Nick Hernandez, CEO at ABISA.  "ABISA's niche within the healthcare industry positions us well for the strategic needs of our clients."

Investors and healthcare providers are seeking support for a variety of business initiatives to expand markets. These may include strategies such as medical tourism, telehealth, and global oncology initiatives. ABISA is an ideal partner to provide that consulting support. The company's success can be attributed to its culture that focuses on professionalism and emphasizes long-term client relationships. "We are very pleased to have been selected to work with these projects," Hernandez said. "The global healthcare sector is ever-changing. Selecting the right partner to support critical initiatives is so important. Our integrity and focused expertise allows our clients to be confident that ABISA will provide the sound advice that they expect."


ABISA is a global healthcare consultancy specializing on healthcare strategy and physician engagement, strategic telehealth initiatives, and global oncology initiatives. ABISA can help devise and implement the strategies and processes that will allow organizations to remain competitive and solvent. For more information, visit or contact us at

Related Links

This content was issued through the press release distribution service at For more info visit:


To view the original version on PR Newswire, visit:




You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
OTC Markets Group Welcomes PixarBio to OTCQX
Cyber Security: Biggest Threat to Medical Devices?